Ante Sven Lundberg

This inventor holds 18 USPTO granted patents and 31 published patent applications and 13 EPO patents. Top assignees: Crispr Therapeutics Ag, Vertex Pharmaceuticals, Inc.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ante Sven Lundberg. Retrieved from https://idiyas.com/inventor/ante-sven-lundberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 31)

% Patents Active = 94.4

EPO Patents = 13 (Patent Applications = 32)

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 16(Granted Patents)

Company Filing History:

9 out of 86

Crispr Therapeutics Ag

patents

9 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

Years Active: 2021-2026

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12644137 - Materials and methods for treatment of hemoglobinopathies (2026-06-02),

2. 12442020 - Materials and methods for treatment of pain related disorders (2025-10-14),

3. 12186406 - Materials and methods for treatment of hereditary haemochromatosis (2025-01-07),

4. 12161674 - CRISPR-CAS9 modified CD34+ human hematopoietic stem and progenitor cells and uses thereof (2024-12-10),

5. 12053531 - Materials and methods for treatment of Duchenne Muscular Dystrophy (2024-08-06),

6. 12043843 - Materials and methods for treatment of hemoglobinopathies (2024-07-23),

7. 11920148 - Compositions and methods for gene editing (2024-03-05),

8. 11866727 - Materials and methods for treatment of glycogen storage disease type 1A (2024-01-09),

9. 11851653 - Materials and methods for treatment of alpha-1 antitrypsin deficiency (2023-12-26),

10. 11801313 - Materials and methods for treatment of pain related disorders (2023-10-31),

11. 11564997 - Materials and methods for treatment of friedreich ataxia and other related disorders (2023-01-31),

12. 11559588 - Materials and methods for treatment of Spinocerebellar Ataxia Type 1 (SCA1) and other Spinocerebellar Ataxia Type 1 Protein (ATXN1) gene related conditions or disorders (2023-01-24),

13. 11459587 - Materials and methods for treatment of pain related disorders (2022-10-04),

14. 11427838 - Materials and methods for treatment of myotonic dystrophy type 1 (DM1) and other related disorders (2022-08-30),

15. 11407997 - Materials and methods for treatment of primary hyperoxaluria type 1 (PH1) and other alanine-glyoxylate aminotransferase (AGXT) gene related conditions or disorders (2022-08-09),

Title: Ante Sven Lundberg - Innovative Inventor from Cambridge

Introduction: Ante Sven Lundberg is a renowned inventor based in Cambridge, MA, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Ante Sven Lundberg holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Lundberg has worked with leading research institutions and tech companies, consistently pushing the boundaries of innovation. His work has been instrumental in shaping the future of technology.

Collaborations: Lundberg has collaborated with top universities and multinational corporations on cutting-edge projects, fostering a culture of innovation and knowledge-sharing. His collaborative efforts have led to the development of revolutionary products and solutions.

Conclusion: Ante Sven Lundberg's passion for innovation and his relentless pursuit of excellence have established him as a visionary inventor in the tech industry, with a legacy that continues to inspire future generations of inventors.

Profile summary based on public USPTO records.